Sign in
INVO Stock Price, Chart, Stats & News
INVO Bioscience, Inc.
Save
3.25M
Market cap
1.21x
Current P/E
–
Forward P/E
INVO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 41.27% |
Operating margin | -253.32% |
Pretax margin | -274.67% |
Net margin | -294.22% |
Effective tax rate | -6.34% |
ROA | -184.12% |
ROE | -564.65% |
D/E | 0.87x |
Interest coverage ratio | 78.82x |
INVO valuation
P/E | 1.21x |
P/S | 0.00x |
P/B | 0.00x |
P/CF | -0.00x |
P/FCF | -0.00x |
P/OCF | -0.00x |
PEG | 0.30x |
EV multiple | 0.15x |
About
INVO Bioscience, Inc. is a globally operating, commercial-phase enterprise focused on fertility, offering advanced solutions in assisted reproductive technology. Their leading product is the INVOcell, an innovative medical device engineered to allow fertilization and the initial development of embryos to naturally occur inside the woman's body. The company, headquartered in Sarasota, Florida, began its operations in 2007.
Similar securities
Based on sector and market capitalization
Report issue